Leukemia risk increased by radioactive iodine treatment for thyroid cancer

Nuclear Information

Radioactive Iodine Increases Risk of Thyroid Cancer Patient Developing Acute Myeloid Leukemia, Study Reports https://lymphomanewstoday.com/2017/09/25/study-shows-leukemia-risk-rises-when-thyroid-cancer-patients-treated-with-radioactive-iodine/ BY JANET STEWART

Using radioactive iodine as a follow-up treatment to thyroid cancer surgery increases the risk of a patient developing acute myeloid leukemia and having a poorer outcome, a study reports.

Researchers presented the findings at the Congress of the European Society for Medical Oncology in Madrid, Sept. 8-12. The presentation was titled “Risk of developing acute myeloid leukemia (AML) in well-differentiated thyroid cancer (WDTC) patients treated with radioactive iodine (RAI): a population-based study.”

Studies have shown that the risk of a patient with another cancer developing acute myeloid leukemia, or AML, increases after radiation.

Researchers decided to study cases of well-differentiated thyroid cancer, or WDTC, that doctors had treated either with surgery or with surgery followed by radioactive iodine. The team looked at cases in a U.S. cancer database known as Surveillance Epidemiology and…

View original post 244 more words

One thought on “Leukemia risk increased by radioactive iodine treatment for thyroid cancer”

Comments are closed.